ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

156 Épisodes

1. ACCEL Lite: Optimizing the Care of ASCVD Patients with T2DM

   Publié: 25/04/2023
2. ACCEL Lite: Revascularization of Stable Ischemic Heart Disease in the Era of COURAGE, ISCHEMIA, and ORBITA

   Publié: 18/04/2023
3. ACCEL Lite: Long-Term Secondary Prevention After PCI or MI: Aspirin, Clopidogrel, DAPT or DPI?

   Publié: 13/04/2023
4. ACCEL Lite: Understanding the Basics of HF-rEF and Work Up

   Publié: 11/04/2023
5. ACCEL Lite: ISCHEMIA-EXTENDed – Follow-Up Interim Report

   Publié: 04/04/2023
6. ACCEL Lite: ACC.23 Late-Breaker: Bempedoic Acid and Cardiovascular Outcomes In Statin Intolerant Patients At High Cardiovascular Risk

   Publié: 28/03/2023
7. ACCEL Lite: When Lifestyle Isn't Enough: Surgical vs. Pharmacological Approaches for Obesity

   Publié: 21/03/2023
8. ACCEL Lite: ACC.23 Late-Breaker: Vigorous Exercise in Individuals with Hypertrophic Cardiomyopathy: Primary Results of the LIVE-HCM Study

   Publié: 14/03/2023
9. ACCEL Lite: Statins To Prevent The Cardiotoxicity From Anthracyclines: The STOP-CA Trial

   Publié: 07/03/2023
10. ACCEL Lite: From JACC: CACS Improves Risk Prediction in Patients with Suspected Obstructive CAD

    Publié: 28/02/2023
11. ACCEL Lite: PRECISE – Comparison of a Precision Care Strategy with Usual Testing to Guide Management of Stable Patients With Suspected CAD

    Publié: 21/02/2023
12. ACCEL Lite: IRONMAN – Randomized Trial of Intravenous Ferric Derisomaltose in HFrEF

    Publié: 14/02/2023
13. PROMINENT – A Randomized Trial of Pemafibrate for Triglyceride Reduction in the Prevention of CVD

    Publié: 07/02/2023
14. ACCEL Lite: AHA Late-Breaker: PROGRESSIVE-AF – The Impact of “First-Line” Rhythm Therapy on Atrial Fibrillation Progression

    Publié: 31/01/2023
15. AHA Late-Breaker: OCEAN(a)-DOSE – Reduction of Lipoprotein(a) With Small Interfering RNA

    Publié: 24/01/2023
16. AHA Late-Breaker: EMPA-KIDNEY – Empagliflozin and CV Outcomes in Patients with CKD

    Publié: 17/01/2023
17. AHA Late-Breaker: TRANSFORM-HF – Comparative Effectiveness of Torsemide versus Furosemide in Heart Failure: Primary Results

    Publié: 10/01/2023
18. ACCEL Lite: Top Takeaways from 2022: General Cardiology with Glenn Hirsch MD

    Publié: 22/12/2022
19. ACCEL Lite: Top Takeaways from 2022: Preventive Cardiology with Martha Gulati MD

    Publié: 20/12/2022
20. ACCEL Lite: Top Takeaways from 2022: Interventional Cardiology with Dipti Itchhaporia MD

    Publié: 13/12/2022